Chen Chih-Chia, Chu Chi-Hsiang, Lin Yung-Chieh, Huang Chao-Ching
Graduate Institute of Clinical Medicine, College of Medicine, National Cheng-Kung University, Tainan, Taiwan.
Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Kidney Int Rep. 2023 Jul 3;8(9):1784-1791. doi: 10.1016/j.ekir.2023.06.020. eCollection 2023 Sep.
This study aimed to assess head circumference (HC) growth and neurodevelopmental outcomes in very preterm-birth children after neonatal acute kidney injury (AKI).
This longitudinal follow-up cohort included 732 very preterm neonates of gestational age <31 weeks admitted to a tertiary center between 2008 and 2020. AKI was categorized as nonoliguric and oliguric AKI based on the urine output criteria during admission. We compared the differences in death, scores of HC (zHC) at term-equivalent age (TEA) and at corrected ages of 6, 12, and 24 months, and the neurodevelopmental outcomes at corrected age of 24 months after neonatal nonoliguric and oliguric AKI.
Among the 154 neonates who developed AKI, 72 had oliguric AKI and 82 had nonoliguric AKI. At TEA, oliguric AKI, but not nonoliguric AKI, was independently associated with lower zHC than non-AKI (mean differences, -0.49; 95% confidence interval [CI], -0.92 to -0.06). Although the 3 groups were comparable in zHC at corrected ages of 6, 12, and 24 months, the oliguric AKI group, but not the nonoliguric AKI group, had a higher rate of microcephaly by corrected age of 24 months. In addition, the oliguric AKI group, but not the nonoliguric AKI group, was more likely to die (61% vs. 9%) and have neurodevelopmental impairment (41% vs. 14%) compare with the non-AKI group. After adjustment, oliguric (adjusted odds ratio [aOR], 8.97; 95% CI, 2.19-36.76), but not nonoliguric, AKI was associated with neurodevelopmental impairment.
Neonatal oliguric AKI is associated with neurodevelopmental impairment in very preterm-birth children. Long-term head-size and neurodevelopmental follow-up after neonatal AKI is warranted.
本研究旨在评估新生儿急性肾损伤(AKI)后极早产儿的头围(HC)生长及神经发育结局。
这项纵向随访队列研究纳入了2008年至2020年间在一家三级中心收治的732例胎龄<31周的极早产儿。根据入院期间的尿量标准,将AKI分为非少尿型AKI和少尿型AKI。我们比较了新生儿非少尿型和少尿型AKI后,死亡、足月相当年龄(TEA)及矫正年龄6个月、12个月和24个月时的HC评分(zHC)差异,以及矫正年龄24个月时的神经发育结局。
在154例发生AKI的新生儿中,72例为少尿型AKI,82例为非少尿型AKI。在TEA时,少尿型AKI而非非少尿型AKI与低于非AKI组的zHC独立相关(平均差异为-0.49;95%置信区间[CI]为-0.92至-0.06)。尽管三组在矫正年龄6个月、12个月和24个月时的zHC相当,但少尿型AKI组而非非少尿型AKI组在矫正年龄24个月时小头畸形发生率更高。此外,与非AKI组相比,少尿型AKI组而非非少尿型AKI组更易死亡(61%对9%)且有神经发育障碍(41%对14%)。调整后,少尿型(调整优势比[aOR]为8.97;95%CI为2.19 - 36.76)而非非少尿型AKI与神经发育障碍相关。
新生儿少尿型AKI与极早产儿的神经发育障碍相关。新生儿AKI后进行长期头围大小及神经发育随访是必要的。